Skip to main content

Day: October 11, 2023

Global Construction Chemicals Market Size to Reach USD 89.78 Billion in 2032 | Emergen Research

Rapid technological innovation in the construction industry is a major factor driving the Construction Chemicals market revenue growth Vancouver, Oct. 11, 2023 (GLOBE NEWSWIRE) — The global Construction Chemicals Market size was USD 49.90 Billion in 2022 and is expected to register a revenue CAGR of 6.0% during the forecast period, according to the latest analysis by Emergen Research. Significant investments in specialized waterproofing and chemical-resistant coatings are major factors driving the market revenue growth. Waterproofing products and solutions are in high demand, especially in regions prone to heavy rainfall or flooding. Construction chemicals for below-grade waterproofing, roof waterproofing, and waterproofing of critical structures are major trends in the global market. Industries that deal with chemicals, such...

Continue reading

Global Beauty and Personal Care Market Size to Reach USD 5,373.09 Billion in 2032 | Emergen Research

Rising demand to blend beauty and wellness with the rapid adoption of cosmetics is a major factor driving beauty and personal care market revenue growth. Vancouver, Oct. 11, 2023 (GLOBE NEWSWIRE) — Global Beauty and Personal Care Market Size to Reach USD 5,373.09 Billion in 2032 | Emergen Research Rising demand to blend beauty and wellness with the rapid adoption of cosmetics is a major factor driving beauty and personal care market revenue growth. The global beauty and personal care market size was USD 518.62 Billion in 2022 and is expected to register a revenue CAGR of 18.5% during the forecast period, according to the latest analysis by Emergen Research. Businesses are working to create brand loyalty in consumers to increase sustainable growth. For instance, Florasis has taken the initiative by pioneering the co-creation model,...

Continue reading

TG Therapeutics Announces Presentation of Data for BRIUMVI at the 2023 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting

NEW YORK, Oct. 11, 2023 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX) today announced the presentation of data from both the ULTIMATE I & II Phase 3 trials and the ENHANCE Phase 3b trial evaluating BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of multiple sclerosis (RMS), at the 2023 European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) annual meeting, being held in Milan, Italy. A link to each presentation is included below. Michael S. Weiss, Chairman and Chief Executive Officer of TG Therapeutics, stated, “The exploratory data from the ULTIMATE I & II trials evaluating BRIUMVI in patients with relapsing forms of MS continues to be exciting and highlights the unique attributes of BRIUMVI. Today at the ECTRIMS annual meeting, we were also excited to present the first data...

Continue reading

TELUS Friendly Future Foundation launches new $50 million TELUS Student Bursary Fund – the largest bursary fund in Canada

Created through a $25 million endowment gift from TELUS plus an additional $25 million in fundraising, the TELUS Student Bursary program will support hundreds of students each year, who are committed to making a difference in their communities, achieve the education they are passionate about realizing 75 per cent of students find it very hard to afford post-secondary education, and nearly 1-in-3 students have considered withdrawing from their studies due to financial difficulty TORONTO, Oct. 11, 2023 (GLOBE NEWSWIRE) — Today, TELUS Friendly Future Foundation announced the launch of Canada’s largest bursary fund: the TELUS Student Bursary, supporting students facing financial barriers impacting their ability to enroll or continue their education. Created through a $25 million endowment gift from TELUS, along with an additional $25...

Continue reading

Global Data Lake Market Size to Reach USD 89.53 Billion in 2032 |Emergen Research

Simplified access to organizational data in departmental silos, mainframe, and legacy systems is a key factor driving global market revenue growth Vancouver, Oct. 11, 2023 (GLOBE NEWSWIRE) — The global data lake market size is expected to reach USD 89.53 Billion in 2032 and register a steady revenue CAGR of 20.6% during the forecast period, according to latest analysis by Emergen Research. Increasing need to extract in-depth insights from rising volumes of data to gain a competitive advantage is a key factor driving market revenue growth. Data lake gathers data from several sources, which is kept in the original format and can be instantly imported. Size of data can be increased using this technique while saving time on the creation of data structures, schema, and transformations. Data lakes allow many roles within an organization,...

Continue reading

Temenos Leads Evolution in Correspondent Banking as Banks Seek to Modernize Cross-Border Payments in the Cloud

Temenos solution supports the rapid addition of new payment rails and payment types, helping banks to stay ahead of market changes and grow profitable cross-border payment services GENEVA, Switzerland, Oct. 11, 2023 (GLOBE NEWSWIRE) — Temenos (SIX: TEMN) has demonstrated how its cloud-native Correspondent Banking solution supports the rapid addition of new alternative payment rails and payment types using payment adaptors and an extensive set of APIs. This helps banks and payment service providers to stay ahead of market changes and to grow profitable cross-border payment services on the back of them. Temenos Correspondent Banking solution includes pre-configured banking capabilities for nostro and vostro account servicing, cash management, cross border payments, treasury, liquidity management, customer onboarding and financial...

Continue reading

The Rocky Horror Show NFTs Embrace Monaco Art Scene with Captivating Fusion Exhibition

Unveiling ‘phygital’ art collection at exclusive contemporary gallery London, UK, Oct. 11, 2023 (GLOBE NEWSWIRE) — La Vitrine Contemporain de Monaco will be hosting The Rocky Horror Show NFTs IRL art exhibition from Tuesday, October 17th 2023.The micro-gallery, in the glamorous principality of Monaco, will be showcasing physical representations of nine The Rocky Horror Show NFTs (non-fungible tokens). Each of the unique artworks will depict a different iconic character from the cult show including Frank-N-Furter, Riff Raff, Janet and Brad. The art has been designed exclusively for the exhibition as part of the ground-breaking musical’s 50th anniversary celebrations. The Rocky Horror Show LVCDM Monaco Collection, in merging the physical and the virtual worlds, offers fans of The Rocky Horror Show a chance to own both a digital...

Continue reading

UPDATE – OTC Markets Group Welcomes DynaResource, Inc. to OTCQX

NEW YORK, Oct. 11, 2023 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for 12,000 U.S. and international securities, today announced DynaResource, Inc. (OTCQX: DYNR), a junior gold resource company, has qualified to trade on the OTCQX® Best Market. DynaResource, Inc. upgraded to OTCQX from the OTCQB® Venture Market. DynaResource, Inc. begins trading today on OTCQX under the symbol “DYNR.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com. The OTCQX Market provides investors with a premium U.S. public market to research and trade the shares of investor-focused companies. Graduating to the OTCQX Market marks an important milestone for companies, enabling them to demonstrate their qualifications and build visibility among...

Continue reading

MoonLake Immunotherapeutics presents positive 12-week data from the Phase 2 MIRA trial with Nanobody® Sonelokimab for Hidradenitis Suppurativa at the European Academy of Dermatology and Venereology Congress

MoonLake Immunotherapeutics presents positive 12-week data from the Phase 2 MIRA trial with Nanobody® Sonelokimab for Hidradenitis Suppurativa at the European Academy of Dermatology and Venereology CongressPeer reviewed data presented during a late-breaking session at the European Academy of Dermatology and Venereology Congress (EADV) confirms the strong profile of sonelokimab in HS announced at MLTX’s R&D Day on June 26, 2023 HiSCR75 primary endpoint met with a significantly higher proportion of patients on sonelokimab 120mg (43.3%) compared to placebo (14.7%) achieving HiSCR75 at week 12; a 29 percentage points (ppt) delta (p

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.